House Representatives Paul Tonko (D-N.Y.) and Vern Buchanan (R-Fla.) have joined forces to tackle one of the most pressing healthcare issues facing our nation today: Alzheimer’s disease. The two congressmen are co-sponsors of the Alzheimer’s Screening and Prevention (ASAP) Act, a groundbreaking piece of legislation that aims to proactively address this devastating disease.
At The Hill’s “Getting a Diagnosis ASAP: Progress in Early Alzheimer’s Detection” event on Thursday, Tonko and Buchanan made their stance clear – Congress simply cannot afford to ignore Alzheimer’s any longer. According to the Alzheimer’s Association, the disease currently affects over 5 million Americans and is the sixth leading cause of death in the United States. As our population ages, these numbers are only expected to rise, making Alzheimer’s a costly and urgent issue that demands immediate attention.
Tonko and Buchanan both have personal connections to Alzheimer’s, with Tonko’s mother-in-law suffering from the disease and Buchanan’s father-in-law passing away from it. Their firsthand experience with the devastating effects of Alzheimer’s has fueled their determination to tackle the issue head on and find solutions that will benefit millions of families across the country.
Speaking at the event, Tonko emphasized the importance of early detection and prevention when it comes to Alzheimer’s. He stressed that by identifying the disease in its early stages, we can not only improve the quality of life for those affected, but also save billions of dollars in healthcare costs.
Buchanan echoed Tonko’s sentiments, stating that Alzheimer’s is “too expensive” of an issue for Congress to ignore. The disease not only takes a toll on families emotionally, but also financially, with the cost of caring for those with Alzheimer’s estimated to be over $290 billion in 2019 alone. This staggering number is expected to rise to $1.1 trillion by 2050 if no action is taken.
The ASAP Act, introduced by Tonko and Buchanan, aims to address these challenges by promoting early detection and offering resources for prevention and treatment. The bill would establish a nationwide education campaign to raise awareness about Alzheimer’s and the importance of early detection. It would also provide grants to healthcare professionals for training and education on early detection and diagnosis, as well as funding for research into potential treatments and cures.
The bipartisan support for the ASAP Act is a testament to the urgency and significance of this issue. Both Tonko and Buchanan are committed to working together to ensure that this legislation becomes a reality and makes a positive impact on the lives of those affected by Alzheimer’s.
But the fight against Alzheimer’s doesn’t end with the ASAP Act. Tonko and Buchanan emphasized the need for continued efforts to address this disease, including investing in research and supporting caregivers. They also called on individuals to take an active role in their own health by being aware of the risk factors and seeking early detection and treatment if necessary.
In closing, Tonko and Buchanan made it clear that Alzheimer’s is a bipartisan issue that requires bipartisan solutions. By tackling this issue head on and investing in early detection and prevention, we can make a significant difference in the lives of those affected by Alzheimer’s. As Tonko aptly stated, “We can’t afford not to address this issue.” Let’s come together to support the ASAP Act and pave the way towards a brighter future for those living with Alzheimer’s.
